Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-25

Clinical Trial Update: Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting potential drug–drug interactions between the study drug and antifungal agents ketoconazole or fluconazole in Alzheimer's disease;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)
  • Ketoconazole (Ketoconazole)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED